Key result
One-Anastomosis gastric bypass (OAGB) achieved significantly greater weight loss and remission of dyslipidemia than Roux-en-Y gastric bypass or sleeve gastrectomy at 5 years.
Why the study?
The study was conducted to compare the long-term weight loss results, remission of comorbidities, and nutritional deficiencies among sleeve gastrectomy, Roux-en-Y gastric bypass, and one-anastomosis gastric bypass in type 2 diabetic patients.
Does One-Anastomosis Gastric Bypass improve weight loss and comorbidity remission compared to Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in morbidly obese patients with type 2 diabetes?
Cohort (n=358)
Does One-Anastomosis Gastric Bypass improve weight loss and comorbidity remission compared to Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in morbidly obese patients with type 2 diabetes?
One-Anastomosis Gastric Bypass provides superior long-term weight loss and dyslipidemia remission compared to Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in morbidly obese patients with type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
Castro et al. (2020) conducted a cohort in Type 2 Diabetes and Morbid Obesity (n=358). One-Anastomosis Gastric Bypass (OAGB) vs. Sleeve Gastrectomy (SG) and Roux-en-Y Gastric Bypass (RYGB) was evaluated on Weight loss and remission of comorbidities. One-Anastomosis gastric bypass (OAGB) achieved significantly greater weight loss and remission of dyslipidemia than Roux-en-Y gastric bypass or sleeve gastrectomy at 5 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: